Pipeline

Contraline is developing a portfolio of male contraceptive products to give men real choices in family planning.

CandidatePreclinicalPhase 1Phase 2Phase 3
NES/Thormonal gel
Phase 2B Completed
ADAMnon-hormonal implant
Phase 2 Ready
NES/T Gel

A phase 2b clinical trial has been completed, demonstrating strong efficacy, safety, and reversibility. Phase 3 trial planning is now underway.

NES/T gel
ADAM Implant

The first-in-human study on ADAM is complete, showing promising safety and efficacy. Planning for Phase 2 is underway.

818 E. Jefferson St. Suite 201, Charlottesville, VA 22902
© 2026 Contraline, Inc. All Rights Reserved.
Contraline’s products are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority.